HK1063637A1 - 17alpha-hydroxy-14beta-steroids with hormonal effect - Google Patents

17alpha-hydroxy-14beta-steroids with hormonal effect

Info

Publication number
HK1063637A1
HK1063637A1 HK04106336A HK04106336A HK1063637A1 HK 1063637 A1 HK1063637 A1 HK 1063637A1 HK 04106336 A HK04106336 A HK 04106336A HK 04106336 A HK04106336 A HK 04106336A HK 1063637 A1 HK1063637 A1 HK 1063637A1
Authority
HK
Hong Kong
Prior art keywords
14beta
17alpha
steroids
hydroxy
hormonal effect
Prior art date
Application number
HK04106336A
Other languages
English (en)
Inventor
Der Louw Van Jaap
Leysen Dirk
De Gooijer Marcel Evert
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1063637(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1063637A1 publication Critical patent/HK1063637A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK04106336A 2001-09-12 2004-08-24 17alpha-hydroxy-14beta-steroids with hormonal effect HK1063637A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12
PCT/EP2002/010041 WO2003022864A1 (fr) 2001-09-12 2002-09-06 Steroides 17alpha-hydroxy-14beta a effet hormonal

Publications (1)

Publication Number Publication Date
HK1063637A1 true HK1063637A1 (en) 2005-01-07

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106336A HK1063637A1 (en) 2001-09-12 2004-08-24 17alpha-hydroxy-14beta-steroids with hormonal effect

Country Status (29)

Country Link
US (1) US7169769B2 (fr)
EP (1) EP1427748B1 (fr)
JP (1) JP4471653B2 (fr)
KR (1) KR100940054B1 (fr)
CN (1) CN1257913C (fr)
AR (1) AR036462A1 (fr)
AT (1) ATE395352T1 (fr)
AU (1) AU2002339536B2 (fr)
BR (1) BR0212409A (fr)
CA (1) CA2505575C (fr)
CY (1) CY1108152T1 (fr)
DE (1) DE60226623D1 (fr)
DK (1) DK1427748T3 (fr)
EC (1) ECSP045012A (fr)
ES (1) ES2305306T3 (fr)
HK (1) HK1063637A1 (fr)
HR (1) HRP20040193A2 (fr)
HU (1) HUP0402139A3 (fr)
IL (2) IL160451A0 (fr)
IS (1) IS2555B (fr)
MX (1) MXPA04002418A (fr)
NO (1) NO326624B1 (fr)
NZ (1) NZ531487A (fr)
PL (1) PL207493B1 (fr)
PT (1) PT1427748E (fr)
RU (1) RU2294332C2 (fr)
TW (1) TWI221154B (fr)
WO (1) WO2003022864A1 (fr)
ZA (1) ZA200401992B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
ATE228143T1 (de) * 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
AU4299301A (en) * 2000-02-29 2001-09-12 National University Of Singapore, The A method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
MXPA04002418A (es) 2004-07-30
KR100940054B1 (ko) 2010-02-04
ATE395352T1 (de) 2008-05-15
WO2003022864A1 (fr) 2003-03-20
NZ531487A (en) 2005-08-26
BR0212409A (pt) 2004-08-03
AU2002339536B2 (en) 2008-04-24
NO20041010L (no) 2004-03-10
IS7165A (is) 2004-02-26
PL207493B1 (pl) 2010-12-31
NO326624B1 (no) 2009-01-19
CN1553917A (zh) 2004-12-08
HUP0402139A3 (en) 2012-12-28
RU2004110934A (ru) 2005-08-20
HRP20040193A2 (en) 2004-08-31
US7169769B2 (en) 2007-01-30
RU2294332C2 (ru) 2007-02-27
JP4471653B2 (ja) 2010-06-02
CN1257913C (zh) 2006-05-31
ECSP045012A (es) 2004-09-27
PT1427748E (pt) 2008-08-27
DK1427748T3 (da) 2008-09-08
PL368727A1 (en) 2005-04-04
CA2505575C (fr) 2010-01-26
TWI221154B (en) 2004-09-21
IL160451A (en) 2009-11-18
US20040259849A1 (en) 2004-12-23
CA2505575A1 (fr) 2003-03-20
IS2555B (is) 2009-10-15
HUP0402139A2 (hu) 2005-02-28
IL160451A0 (en) 2004-07-25
ZA200401992B (en) 2005-04-21
EP1427748B1 (fr) 2008-05-14
EP1427748A1 (fr) 2004-06-16
KR20040039346A (ko) 2004-05-10
JP2005505566A (ja) 2005-02-24
CY1108152T1 (el) 2014-02-12
DE60226623D1 (de) 2008-06-26
AR036462A1 (es) 2004-09-08
ES2305306T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
DE50202400D1 (en) Baw-resonator
DE60237965D1 (en) Metalloproteinaseinhibitoren
DE60234996D1 (en) Photovervielfacher
GB2392916B (en) Deicing
DE60231872D1 (en) Echinocandinverfahren
GB0227332D0 (en) Mailer-ID
DE50214962D1 (en) Heterocyclylarylsulfonamide
HK1063637A1 (en) 17alpha-hydroxy-14beta-steroids with hormonal effect
GB0112053D0 (en) Bacsac
CA93647S (en) Fauteuil
CA93075S (en) Travelbag
GB0128687D0 (en) Microloc
GB0116974D0 (en) Plant-remover
PL348560A1 (en) Palstometer
PL348557A1 (en) Palstometer
PL111833U1 (en) Sepulchre
HU2268U (en) Injection-apparatus
GR2002341Y (en) Euroconverter
GB0210130D0 (en) Rotavators
GB0130838D0 (en) Putter-heads
AU145258S (en) Bath-seat
GB0128527D0 (en) Multisprit
GB0127179D0 (en) Degravitator
GB0125330D0 (en) Gumdinger
GB0119907D0 (en) E-locator

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120906